Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) (vol 18, 762, 2018)

Affiliation auteurs!!!! Error affiliation !!!!
TitreResectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) (vol 18, 762, 2018)
Type de publicationJournal Article
Year of Publication2020
AuteursSchwarz L, Vernerey D, Bachet J-B, Tuech J-J, Portales F, Michel P, Cunha ASa
JournalBMC CANCER
Volume20
Pagination168
Date PublishedMAR 3
Type of ArticleCorrection
DOI10.1186/s12885-020-6678-x